Zions Bancorporation, N.A. Seagen Inc. Transaction History

Zions Bancorporation, N.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$187.64 - $206.25 $1,501 - $1,650	8 Added 21.05%	46 $8,000
Q1 2023 May 10, 2023	BUY	$127.59 - $203.08 $2,296 - $3,655	18 Added 90.0%	38 $7,000
Q4 2022 Feb 10, 2023	SELL	$117.37 - $139.17 $117 - $139	-1 Reduced 4.76%	20 $2,000
Q2 2022 Aug 05, 2022	BUY	$108.81 - $179.33 $544 - $896	5 Added 31.25%	21 $4,000
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $6,937 - $9,155	-58 Reduced 78.38%	16 $2,000
Q4 2021 Feb 11, 2022	BUY	$142.57 - $190.86 $2,138 - $2,862	15 Added 25.42%	74 $11,000
Q3 2021 Nov 10, 2021	BUY	$142.45 - $169.82 $1,851 - $2,207	13 Added 28.26%	59 $10,000
Q2 2021 Aug 11, 2021	BUY	$135.08 - $161.1 $4,052 - $4,833	30 Added 187.5%	46 $7,000
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $1,100 - $1,526	-8 Reduced 33.33%	16 $2,000
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $3,951 - $5,086	24 New	24 $4,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

Stay updated on Zions Bancorporation, N.A. with notifications on news.